This is the authors' abstract. We don't add key points for this paper.
OBJECTIVE: Chronic musculoskeletal pain is common and lacks effective long-term therapies. Transcutaneous electrical nerve stimulation (TENS) and electrical muscle stimulation (EMS) offer noninvasive alternatives, but conventional devices are limited by static protocols and poor adherence. The NXTSTIM EcoAI platform integrates TENS/EMS with artificial intelligence to deliver personalized, adaptive therapy. This study examined 24-month real-world outcomes of EcoAI, focusing on usage and subgroup-level efficacy. METHODS: A retrospective analysis was conducted using de-identified data from 2,050 adults using EcoAI at home. The primary endpoint was change in pain intensity (0-10 numeric rating scale). Secondary endpoints included functional status, session engagement, and qualitative pain self-efficacy. Older adults (≥60 years) achieved comparable or greater relief despite slightly lower usage. No serious adverse events occurred. Findings aligned with prior EcoAI analyses showing optimal outcomes with 2-4 daily sessions of 20-59 minutes. CONCLUSION: EcoAI provided clinically meaningful, durable pain relief with improved function and mood, supporting personalized home-based neuromodulation as a safe, effective adjunct for chronic musculoskeletal pain.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Green et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: